ifosfamide has been researched along with Carcinoma, Small Cell in 209 studies
Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient with a small-cell lung cancer (SCLC) developed an asymptomatic hyponatremia, with all features of the syndrome of inappropriate antidiuretic hormone secretion (SIADH), two days after the start of his first cycle of chemotherapy with vindesine, ifosfamide and cisplatin." | 4.80 | Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: case report and literature review. ( Paridaens, R; Vanhees, SL; Vansteenkiste, JF, 2000) |
| "There was only one postsurgical death." | 2.74 | Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer. ( Dinney, CP; Grossman, HB; Kamat, AM; Millikan, RE; Qiao, W; Siefker-Radtke, AO; Thall, PF; Williams, DL, 2009) |
| "Different dose schedules of ifosfamide were combined with fixed doses of paclitaxel 175 mg/m2 and carboplatin AUC 6 mg/ml min." | 2.70 | Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancer. ( Beijnen, JH; Groen, HJ; Kerbush, T; Sleijfer, DT; Smit, EF; van Putten, JW; van Rijswijk, R, 2001) |
| "The ifosfamide dose was escalated as follows: 3000 mg/m2 (level 1), 5000 mg/m2 (level 2), 7000 mg/m2 (level 3), 9000 mg/m2 (level 4)." | 2.69 | A phase I dose escalation study of multicyclic, dose-intensive chemotherapy with peripheral blood stem cell support for small cell lung cancer. ( Arakawa, M; Chou, D; Gejyo, F; Ito, K; Kagamu, H; Sakai, K; Shimbo, T; Suzuki, E; Takahashi, M; Tanaka, H; Tanaka, J; Wakabayashi, M; Yoshizawa, H, 2000) |
| "To determine the population pharmacokinetic (PK) parameters of doxorubicin (Dox), etoposide (Eto) and ifosfamide (Ifo) in small cell lung cancer (SCLC) patients, to assess the potential relationship between those parameters and to estimate the impact of individual morphological and biological covariates on patients' PK parameters." | 2.69 | Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study. ( Ardiet, C; Boissel, JP; Court-Fortune, I; Freyer, G; Girard, P; Ligneau, B; Rebattu, P; Riou, R; Souquet, PJ; Tranchand, B; Trillet-Lenoir, V, 2000) |
| " The dosage of paclitaxel was escalated from 75 to 225 mg/m2." | 2.68 | A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer. ( Carey, RW; Elias, AD; Grossbard, ML; Jacobs, C; Jauss, S; Kwiatkowski, DJ; Lynch, TJ; Shulman, LN; Strauss, GM; Sugarbaker, DJ, 1995) |
| "Ifosfamide is a chiral pro-drug which is administered clinically in its racemic form." | 2.68 | Pharmacokinetics of ifosfamide and its enantiomers following a single 1 h intravenous infusion of the racemate in patients with small cell lung carcinoma. ( Chrystyn, H; Corlett, SA; Parker, D, 1995) |
| "The addition of IFN-alpha to induction CT appears to confer a survival benefit to SCLC patients but optimal dosing schedule has yet to be defined." | 2.68 | Interferon alpha-2a and combined chemotherapy as first line treatment in SCLC patients: a randomized trial. ( Charitopoulos, K; Dimitriadis, K; Economides, D; Maglaveras, N; Papagiannis, A; Vamvalis, C; Zarogoulidis, K; Ziogas, E, 1996) |
| "Paclitaxel was escalated from 75 to 225 mg/m2 in 25-mg/m2 increments." | 2.68 | Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis. ( Carey, RW; Elias, AD; Grossbard, ML; Herbst, R; Jacobs, C; Kwiatkowski, DJ; Leong, T; Lynch, C; Lynch, TJ; Skarin, AT; Strauss, GM, 1997) |
| "Levels of depression were lower and showed little change." | 2.67 | A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party. ( Bleehen, NM; Girling, DJ; Machin, D; Stephens, RJ, 1993) |
| "Oral etoposide was given on days 1-5, 15-19, and 29-33." | 2.67 | A randomised study of intravenous bolus versus continuous infusion of ifosfamide and doxorubicin with oral etoposide for small-cell lung cancer. ( Anderson, H; Prendiville, J; Radford, JA; Swindell, R; Thatcher, N, 1991) |
| " We therefore investigated the therapeutic efficacy of STI571, alone or combined with chemotherapy, in human SCLC cells or tumors xenografted into nude mice." | 2.43 | In vivo efficacy of STI571 in xenografted human small cell lung cancer alone or combined with chemotherapy. ( de Cremoux, P; Decaudin, D; Fréneaux, P; Judde, JG; Livartowski, A; Nemati, F; Pouillart, P; Poupon, MF; Sastre, X; Tran-Perennou, C, 2005) |
| "Ifosfamide has been found to have antineoplastic activity in a variety of solid tumors." | 2.39 | The role of ifosfamide in germ cell tumors and small cell lung cancer. ( Nichols, CR, 1995) |
| "Ifosfamide has the broad range of clinical activity, but its ultimate role as part of initial therapy remains to be discerned." | 2.38 | Clinical trials with ifosfamide: the Indiana University experience. ( Einhorn, LH; Loehrer, PJ; Nichols, CR; Williams, SD, 1992) |
| " A policy of no dosage reduction is feasible in patients receiving combination chemotherapy with ifosfamide given as a 24-hour intravenous (IV) infusion, which is much more convenient than the more commonly used 4- to 5-day fractionated regimen." | 2.38 | Novel approaches with ifosfamide in small cell lung cancer. ( Cerny, T; De Campos, E; Lind, M; Thatcher, N, 1992) |
| " The aim of this study was to assess the efficacy and safety of ifosfamide in combination with carboplatin and etoposide (ICE) in previously untreated patients with SCLC." | 1.42 | Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer. ( Koo, DH; Lee, HS; Lee, SS; Lee, YG; Lim, SY; Nam, H; Oh, S; Song, JU, 2015) |
| "Paclitaxel (175 mg/m(2)) was administered on day 1 and ifosfamide (2500 mg/m(2)) on day 1-2 every 3 weeks." | 1.34 | Combination chemotherapy with paclitaxel and ifosfamide as the third-line regimen in patients with heavily pretreated small cell lung cancer. ( Ahn, JS; Ahn, MJ; Hong, YS; Hwang, IG; Kang, WK; Lee, J; Lee, SC; Lim, H; Park, BB; Park, JO; Park, K; Park, S, 2007) |
| "The response rate in brain metastases was 50." | 1.31 | Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer. ( Fujita, A; Fukuoka, S; Sekine, K; Tagaki, S; Takabatake, H, 2000) |
| "The aim of this study was to develop a population pharmacokinetic model that could describe the pharmacokinetics of ifosfamide." | 1.31 | Population pharmacokinetics of ifosfamide and its 2- and 3-dechloroethylated and 4-hydroxylated metabolites in resistant small-cell lung cancer patients. ( Beijnen, JH; Groen, HJ; Huitema, AD; Kerbusch, T; Mathĵt, RA; vanPutten, JW, 2001) |
| " These results compare favourably with other combined modality studies, using multiple radiotherapy fractions with cisplatin-based combinations and dosage reduction for patients staged in more anatomical detail." | 1.29 | Therapy for small cell lung cancer using carboplatin, ifosfamide, etoposide (without dose reduction), mid-cycle vincristine with thoracic and cranial irradiation. ( Burt, P; Hicks, F; Leahy, B; Lorigan, P; Prendiville, J; Stout, R; Thatcher, N, 1994) |
| " The dosage of IEP in this study caused moderate toxicity." | 1.29 | Ifosfamide, epirubicin and cisplatin (IEP): another active combination for small cell lung cancer (SCLC). ( Jiamsriponges, K; Thongprasert, S, 1993) |
| "Cerebral metastases occurred in 20% of all patients and was the apparent sole site of relapse in 11% of the CR patients." | 1.28 | Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy. ( Burt, P; Prendiville, J; Radford, J; Ranson, M; Steward, W; Stout, R; Thatcher, N, 1991) |
| "Ifosfamide has a similar spectrum of antitumor activity but has different pharmacokinetics that could provide advantages in efficacy." | 1.28 | Ifosfamide vs cyclophosphamide in cancer therapy. ( Weiss, RB, 1991) |
| " Treatment was repeated every 3 weeks for a maximum of six courses and no dosage reductions were allowed." | 1.28 | Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosis. ( Bronchud, MH; Kamthan, AG; Lind, MJ; Ranson, MR; Steward, WP; Stout, R; Thatcher, N, 1990) |
| "The course of 72 patients (36 with squamous carcinoma, 25 with adenocarcinoma, two with alveolar-cell carcinoma and nine with large-cell carcinoma) could be evaluated." | 1.27 | [Chemotherapy of the non-small cell carcinoma of the lung with ifosfamide and cisplatin]. ( Abel, U; Dirks, HP; Drings, P; Grimm, V; Heinrich, S; Kleckow, M; Manke, HG; Queisser, W; Stiefel, P, 1984) |
| "The most frequent histology was squamous cell carcinoma found in 20 patients." | 1.27 | [Chemotherapy with mitomycin C, vindesine and ifosfamide in the treatment of inoperable non-small cell bronchial carcinoma]. ( Gatzemeier, U; Hossfeld, DK; Radenbach, D; Zschaber, R, 1985) |
| "Ifosfamide at 5 g/m2 was given as a bolus to 48 patients with advanced progressing non-small cell lung cancer." | 1.27 | Ifosfamide by bolus as treatment for advanced non-small cell lung cancer. ( Anderson, H; Hilton, A; Rahman, A; Smith, DB; Steward, WP; Thatcher, N; Webb, K, 1986) |
| "The etoposide combination was tolerated better." | 1.27 | Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer. ( Abel, U; Bülzebruck, H; Drings, P; Kleckow, M; Manke, HG; Stiefel, P, 1986) |
| "Ifosfamide was administered to 21 patients with recurrent or disseminated lung cancer at a dose of 4." | 1.26 | Ifosfamide in the treatment of recurrent or disseminated lung cancer: a phase II study of two dose schedules. ( Costanzi, JJ; Gagliano, R; Hokanson, JA; Loukas, D; Panettiere, FJ, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 52 (24.88) | 18.7374 |
| 1990's | 100 (47.85) | 18.2507 |
| 2000's | 53 (25.36) | 29.6817 |
| 2010's | 3 (1.44) | 24.3611 |
| 2020's | 1 (0.48) | 2.80 |
| Authors | Studies |
|---|---|
| Miyoshi, AI | 1 |
| Ueda, Y | 1 |
| Kurita, T | 1 |
| Kimura, T | 1 |
| Yoshino, K | 1 |
| Yin, ZM | 1 |
| Yu, AJ | 1 |
| Wu, MJ | 1 |
| Fang, J | 1 |
| Liu, LF | 1 |
| Zhu, JQ | 1 |
| Yu, H | 1 |
| Lee, HS | 1 |
| Lee, YG | 1 |
| Koo, DH | 1 |
| Oh, S | 1 |
| Nam, H | 1 |
| Song, JU | 1 |
| Lim, SY | 2 |
| Lee, SS | 1 |
| Siefker-Radtke, AO | 1 |
| Kamat, AM | 1 |
| Grossman, HB | 1 |
| Williams, DL | 1 |
| Qiao, W | 1 |
| Thall, PF | 1 |
| Dinney, CP | 1 |
| Millikan, RE | 1 |
| Jacot, W | 1 |
| Pujol, JL | 1 |
| Chakra, M | 1 |
| Molinier, O | 1 |
| Bozonnat, MC | 1 |
| Gervais, R | 1 |
| Quantin, X | 1 |
| Ettinger, DS | 5 |
| Finkelstein, DM | 1 |
| Ritch, PS | 2 |
| Lincoln, ST | 1 |
| Blum, RH | 1 |
| Oelmann, E | 1 |
| Thomas, M | 1 |
| Serve, H | 1 |
| Kienast, J | 1 |
| Zühlsdorf, M | 1 |
| Mohr, M | 1 |
| Klinke, F | 1 |
| Dölken, G | 1 |
| Macha, H | 1 |
| Schmidt, EW | 1 |
| Berdel, WE | 1 |
| Hand, S | 1 |
| Baker, J | 1 |
| Smith, AP | 1 |
| Macbeth, FR | 1 |
| Socinski, MA | 1 |
| Neubauer, MA | 1 |
| Olivares, J | 1 |
| Ketchel, S | 1 |
| Tynan, M | 1 |
| Moore, M | 1 |
| Lee, JH | 1 |
| Davis, K | 1 |
| Schell, M | 1 |
| Garfield, D | 1 |
| Dalpiaz, O | 1 |
| al Rabi, N | 1 |
| Galfano, A | 1 |
| Martignoni, G | 1 |
| Ficarra, V | 1 |
| Artibani, W | 1 |
| Snee, MP | 1 |
| Unsal, M | 1 |
| Erturk, D | 1 |
| Ichiki, M | 1 |
| Gohara, R | 1 |
| Rikimaru, T | 1 |
| Kitajima, T | 1 |
| Fujiki, R | 1 |
| Shimada, A | 1 |
| Aizawa, H | 1 |
| Margery, J | 1 |
| Le Moulec, S | 1 |
| Grassin, F | 1 |
| Guigay, J | 1 |
| Vaylet, F | 1 |
| L'her, P | 1 |
| Agra, Y | 1 |
| Pelayo, M | 1 |
| Sacristan, M | 1 |
| Sacristán, A | 1 |
| Serra, C | 1 |
| Bonfill, X | 1 |
| Marangolo, M | 3 |
| Giovanis, P | 1 |
| Chrystal, K | 1 |
| Cheong, K | 1 |
| Harper, P | 1 |
| Decaudin, D | 1 |
| de Cremoux, P | 2 |
| Sastre, X | 1 |
| Judde, JG | 1 |
| Nemati, F | 2 |
| Tran-Perennou, C | 1 |
| Fréneaux, P | 1 |
| Livartowski, A | 2 |
| Pouillart, P | 2 |
| Poupon, MF | 2 |
| Bex, A | 1 |
| Nieuwenhuijzen, JA | 1 |
| Kerst, M | 1 |
| Pos, F | 1 |
| van Boven, H | 1 |
| Meinhardt, W | 1 |
| Horenblas, S | 1 |
| Lorigan, P | 3 |
| Woll, PJ | 4 |
| O'Brien, ME | 1 |
| Ashcroft, LF | 1 |
| Sampson, MR | 1 |
| Thatcher, N | 23 |
| Iwasaki, Y | 1 |
| Nagata, K | 1 |
| Nakanishi, M | 1 |
| Natuhara, A | 1 |
| Kubota, Y | 1 |
| Ueda, M | 1 |
| Arimoto, T | 3 |
| Hara, H | 1 |
| Qian, W | 1 |
| Clark, PI | 1 |
| Hopwood, P | 3 |
| Sambrook, RJ | 1 |
| Owens, R | 1 |
| Stephens, RJ | 3 |
| Girling, DJ | 3 |
| Galsky, MD | 1 |
| Iasonos, A | 1 |
| Mironov, S | 1 |
| Scattergood, J | 1 |
| Donat, SM | 1 |
| Bochner, BH | 1 |
| Herr, HW | 1 |
| Russo, P | 1 |
| Boyle, MG | 1 |
| Bajorin, DF | 1 |
| Buchholz, E | 1 |
| Manegold, C | 1 |
| Pilz, L | 1 |
| Drings, P | 13 |
| Veronesi, G | 1 |
| Scanagatta, P | 1 |
| Leo, F | 1 |
| De Pas, T | 1 |
| Pelosi, G | 1 |
| Catalano, G | 1 |
| Gandini, S | 1 |
| De Braud, F | 1 |
| Spaggiari, L | 1 |
| Park, S | 1 |
| Ahn, MJ | 1 |
| Ahn, JS | 1 |
| Lee, J | 1 |
| Hong, YS | 1 |
| Park, BB | 1 |
| Lee, SC | 1 |
| Hwang, IG | 1 |
| Park, JO | 1 |
| Lim, H | 1 |
| Kang, WK | 1 |
| Park, K | 2 |
| Talarico, F | 1 |
| Iusco, D | 1 |
| Negri, L | 1 |
| Belinelli, D | 1 |
| Brunello, A | 1 |
| Basso, U | 1 |
| Rossi, E | 1 |
| Stefani, M | 1 |
| Ghiotto, C | 1 |
| Marino, D | 1 |
| Crivellari, G | 1 |
| Monfardini, S | 1 |
| Grosshans, DR | 1 |
| Meyers, CA | 1 |
| Allen, PK | 1 |
| Davenport, SD | 1 |
| Komaki, R | 3 |
| Leyvraz, S | 4 |
| Pampallona, S | 3 |
| Martinelli, G | 1 |
| Ploner, F | 1 |
| Perey, L | 4 |
| Aversa, S | 1 |
| Peters, S | 1 |
| Brunsvig, P | 1 |
| Montes, A | 1 |
| Lange, A | 3 |
| Yilmaz, U | 1 |
| Rosti, G | 3 |
| Bunn, PA | 3 |
| Stiefel, P | 3 |
| Dirks, HP | 1 |
| Grimm, V | 1 |
| Kleckow, M | 2 |
| Manke, HG | 5 |
| Queisser, W | 2 |
| Abel, U | 2 |
| Heinrich, S | 1 |
| Liesenfeld, A | 1 |
| Havemann, K | 8 |
| Gropp, C | 4 |
| Seifert, W | 1 |
| Thomas, C | 1 |
| Mahnke, HG | 1 |
| Westerhausen, M | 1 |
| Wellens, W | 1 |
| Konrad, RM | 1 |
| Valdivieso, M | 5 |
| Tenczynski, TF | 1 |
| Rodriguez, V | 1 |
| Burgess, MA | 2 |
| Mountain, CF | 1 |
| Barkley, HT | 3 |
| Hersh, EM | 1 |
| Bodey, GP | 3 |
| Saiers, JH | 1 |
| Slavik, M | 1 |
| Kokron, O | 2 |
| Micksche, M | 1 |
| Titscher, R | 1 |
| Wrba, H | 1 |
| Karrer, K | 2 |
| Denck, H | 2 |
| Pridun, N | 1 |
| Zwintz, E | 1 |
| Serrou, B | 1 |
| Cupissol, D | 1 |
| Plagne, R | 1 |
| Boutin, P | 1 |
| Carcassone, Y | 1 |
| Michel, FB | 1 |
| Nakhosteen, JA | 1 |
| Niederle, N | 2 |
| Harrison, EF | 1 |
| Hawke, JE | 1 |
| Hunter, HL | 1 |
| Costanzi, JJ | 3 |
| Morgan, LR | 2 |
| Plotkin, D | 1 |
| Tucker, WG | 1 |
| Worrall, PM | 1 |
| Hokanson, J | 1 |
| Holoye, PY | 3 |
| Anderson, T | 1 |
| Duelge, J | 1 |
| Hansen, RM | 1 |
| Kehl, A | 1 |
| Bergholz, M | 1 |
| von Heyden, HW | 1 |
| Nagel, GA | 1 |
| Mukouda, K | 1 |
| Morikawa, E | 1 |
| Hasegawa, K | 1 |
| Noumi, K | 1 |
| Ohmura, T | 1 |
| Mishima, Y | 1 |
| Kawamoto, M | 1 |
| Inagaki, A | 1 |
| Kamitsuna, A | 1 |
| Yamakido, M | 1 |
| Nishimoto, Y | 1 |
| Koyama, T | 1 |
| Katsuta, S | 1 |
| Bakowski, MT | 1 |
| Crouch, JC | 1 |
| Cabanillas, F | 1 |
| Keating, M | 1 |
| Murphy, WK | 5 |
| Frazier, H | 1 |
| Chen, T | 1 |
| Seeber, S | 1 |
| Dimitriadis, K | 2 |
| Schütte, J | 1 |
| Schmidt, CG | 2 |
| Bleehen, NM | 2 |
| Machin, D | 2 |
| Brugger, W | 4 |
| Henschler, R | 1 |
| Heimfeld, S | 1 |
| Berenson, RJ | 1 |
| Mertelsmann, R | 4 |
| Kanz, L | 4 |
| Pettengell, R | 2 |
| Dexter, TM | 2 |
| Testa, NG | 2 |
| Frommhold, H | 3 |
| Pressler, K | 1 |
| Hodgetts, J | 2 |
| Lomax, L | 2 |
| Bildet, F | 1 |
| Cour-Chabernaud, V | 1 |
| Strauss, GM | 2 |
| Lynch, TJ | 2 |
| Elias, AD | 2 |
| Jacobs, C | 2 |
| Kwiatkowski, DJ | 2 |
| Shulman, LN | 1 |
| Carey, RW | 2 |
| Grossbard, ML | 2 |
| Jauss, S | 1 |
| Sugarbaker, DJ | 1 |
| Postmus, PE | 8 |
| Smit, EF | 4 |
| Loehrer, PJ | 8 |
| Ansari, R | 5 |
| Gonin, R | 2 |
| Monaco, F | 1 |
| Fisher, W | 2 |
| Sandler, A | 2 |
| Einhorn, LH | 7 |
| Brewster, AE | 1 |
| Stout, R | 9 |
| Burt, PA | 2 |
| Wolff, AC | 1 |
| Neuberg, D | 1 |
| Comis, RL | 1 |
| Ruckdeschel, JC | 1 |
| Bonomi, PD | 1 |
| Johnson, DH | 2 |
| de Campos, E | 2 |
| Radford, J | 2 |
| Steward, W | 2 |
| Milroy, R | 1 |
| Dougal, M | 1 |
| Swindell, R | 4 |
| Testa, N | 1 |
| Nichols, CR | 2 |
| Lee, SM | 2 |
| Betticher, D | 1 |
| Woodhead, M | 1 |
| Weir, D | 1 |
| Hanley, S | 1 |
| Hardy, C | 1 |
| Corlett, SA | 1 |
| Parker, D | 1 |
| Chrystyn, H | 1 |
| Hatton, MQ | 1 |
| Cassidy, J | 2 |
| Bicknell, S | 1 |
| Semple, P | 1 |
| Stack, B | 1 |
| Steward, WP | 4 |
| Faylona, EA | 1 |
| Sandler, AB | 2 |
| Watanabe, Y | 1 |
| Tanaka, H | 2 |
| Ogawa, M | 1 |
| Tanaka, T | 1 |
| Tanizawa, M | 1 |
| Cargill, RI | 1 |
| Boyter, AC | 1 |
| Lipworth, BJ | 1 |
| Elisson, LO | 1 |
| Ekberg, L | 1 |
| Sculier, JP | 3 |
| Bureau, G | 2 |
| Giner, V | 3 |
| Thiriaux, J | 2 |
| Michel, J | 3 |
| Berchier, MC | 3 |
| Van Cutsem, O | 3 |
| Küstner, U | 2 |
| Kroll, F | 2 |
| Mommen, P | 3 |
| Prendiville, J | 4 |
| Hicks, F | 1 |
| Leahy, B | 1 |
| Burt, P | 3 |
| Thongprasert, S | 3 |
| Phromwas, N | 1 |
| Atikachi, B | 1 |
| Jiemsripong, K | 1 |
| Moro, D | 1 |
| Orfeuvre, H | 1 |
| Nagy-Mignotte, H | 1 |
| Mousseau, M | 1 |
| Blanc-Jouvan, F | 1 |
| Schaerer, R | 1 |
| Brambilla, C | 1 |
| Lorrigan, P | 1 |
| Trillet-Lenoir, V | 3 |
| Mornex, F | 1 |
| Chauvin, F | 2 |
| Fournel, P | 1 |
| Voloch, A | 1 |
| Perol, M | 2 |
| Laennec, E | 1 |
| Piperno, D | 1 |
| Boyer, J | 1 |
| Ardiet, JM | 1 |
| Jiamsriponges, K | 1 |
| van der Graaf, WT | 1 |
| Haaxma-Reiche, H | 2 |
| Burghouts, JT | 3 |
| Evans, WK | 2 |
| Stewart, DJ | 1 |
| Shepherd, FA | 2 |
| Logan, D | 2 |
| Goss, G | 2 |
| Maroun, JA | 1 |
| Wierzbicki, R | 1 |
| Warner, E | 2 |
| Latreille, J | 2 |
| Dahrouge, S | 2 |
| Kirkpatrick, A | 3 |
| Splinter, TA | 4 |
| Cameron, JC | 1 |
| Johnson, BE | 1 |
| Kaye, SB | 1 |
| Anderson, H | 5 |
| Radford, JA | 2 |
| Ashcroft, L | 1 |
| Köpf-Maier, P | 1 |
| Sass, G | 1 |
| Wahid, NA | 1 |
| Neugut, AI | 1 |
| Hibshoosh, H | 1 |
| Brunetti, JC | 1 |
| Fountain, KS | 1 |
| Rubin, M | 1 |
| Paesmans, M | 2 |
| Lecomte, J | 2 |
| Sergysels, R | 1 |
| Klastersky, J | 2 |
| Lokich, J | 1 |
| Anderson, N | 1 |
| Moore, C | 1 |
| Bern, M | 1 |
| Coco, F | 1 |
| Dow, E | 1 |
| Soler, P | 1 |
| Arpin, D | 1 |
| Bohas, C | 1 |
| Riou, R | 2 |
| Court-Fortune, I | 2 |
| Ecochard, D | 1 |
| Cordier, JF | 2 |
| Zarogoulidis, K | 2 |
| Ziogas, E | 2 |
| Papagiannis, A | 2 |
| Charitopoulos, K | 1 |
| Economides, D | 1 |
| Maglaveras, N | 1 |
| Vamvalis, C | 2 |
| Bosquée, L | 3 |
| Pasini, F | 2 |
| Humblet, Y | 3 |
| Hamdan, O | 1 |
| Cetto, GL | 1 |
| Scagliotti, G | 1 |
| Groen, HJ | 3 |
| Gozzelino, F | 1 |
| Curran, D | 1 |
| Sahmoud, T | 1 |
| Giaccone, G | 1 |
| Kurowski, V | 1 |
| Wagner, T | 1 |
| Fetscher, S | 2 |
| Engelhardt, R | 2 |
| Hasse, J | 2 |
| Wenger, M | 1 |
| Lange, W | 2 |
| Hastürk, S | 1 |
| Kurt, B | 1 |
| Kocabas, A | 1 |
| Orüç, O | 1 |
| Burgut, R | 1 |
| Chen, YM | 3 |
| Wu, MF | 3 |
| Perng, RP | 3 |
| Chou, CM | 1 |
| Yang, KY | 1 |
| Lin, WC | 2 |
| Tsai, CM | 2 |
| Liu, JM | 3 |
| Whang-Peng, J | 3 |
| Herbst, R | 1 |
| Leong, T | 1 |
| Lynch, C | 1 |
| Skarin, AT | 1 |
| Yang, SL | 1 |
| Okada, Y | 1 |
| Kawakami, S | 1 |
| Fukuda, H | 1 |
| Nagahama, K | 1 |
| Saito, K | 1 |
| Ohtsuka, Y | 1 |
| Kihara, K | 1 |
| Morita, T | 1 |
| Oshima, H | 1 |
| Eishi, Y | 1 |
| Kanno, J | 1 |
| Glisson, B | 3 |
| Lee, JS | 3 |
| Palmer, J | 1 |
| Fossella, F | 2 |
| Shin, DM | 2 |
| Perez-Soler, R | 2 |
| Hong, WK | 2 |
| Kurie, J | 1 |
| Schea, R | 1 |
| Vadhan-Raj, S | 1 |
| von Pawel, J | 1 |
| Gatzemeier, U | 2 |
| Woll, P | 1 |
| Koschel, G | 1 |
| Clancy, L | 1 |
| Verweij, J | 1 |
| de Wit, R | 1 |
| Pfeifer, W | 1 |
| Fennelly, J | 1 |
| von Eiff, M | 1 |
| Frisch, J | 1 |
| Fujita, A | 3 |
| Takabatake, H | 3 |
| Tagaki, S | 3 |
| Sekine, K | 3 |
| Fahantidou, E | 1 |
| Dermitzakis, G | 1 |
| Gioulekas, D | 1 |
| Wu, HW | 1 |
| Tjan-Heijnen, VC | 1 |
| Biesma, B | 1 |
| Festen, J | 3 |
| Cox, A | 1 |
| Wagener, DJ | 1 |
| Shevlin, PM | 2 |
| Muers, MF | 3 |
| Peake, MD | 3 |
| Hosker, HS | 2 |
| Stead, ML | 2 |
| Poulter, KM | 3 |
| Brown, JM | 3 |
| Ali, MA | 2 |
| Kraut, MJ | 2 |
| Herskovic, AM | 1 |
| Du, W | 1 |
| Kalemkerian, GP | 2 |
| Skarlos, DV | 1 |
| Samantas, E | 1 |
| Pectasides, D | 1 |
| Pavlidis, N | 1 |
| Kalofonos, C | 1 |
| Klouvas, G | 1 |
| Panoussaki, E | 1 |
| Tsiakopoulos, E | 1 |
| Poulakis, N | 1 |
| Fountzilas, G | 1 |
| Wasserfallen, JB | 1 |
| Rollier, P | 1 |
| Philip, PA | 1 |
| Rea, D | 1 |
| Mitchell, K | 1 |
| Carmichael, J | 1 |
| Harris, AL | 4 |
| Talbot, DC | 1 |
| Roganovich, J | 1 |
| Bisogno, G | 1 |
| Cecchetto, G | 1 |
| D'Amore, ES | 1 |
| Carli, M | 1 |
| Peters, R | 1 |
| van de Velde, H | 1 |
| Weynants, P | 1 |
| Canon, JL | 1 |
| Rosier, JF | 1 |
| Takahashi, M | 1 |
| Yoshizawa, H | 1 |
| Tanaka, J | 1 |
| Kagamu, H | 1 |
| Ito, K | 1 |
| Shimbo, T | 1 |
| Chou, D | 1 |
| Wakabayashi, M | 1 |
| Suzuki, E | 1 |
| Sakai, K | 1 |
| Arakawa, M | 1 |
| Gejyo, F | 1 |
| Ruotsalainen, T | 1 |
| Halme, M | 1 |
| Isokangas, OP | 1 |
| Pyrhönen, S | 1 |
| Mäntylä, M | 1 |
| Pekonen, M | 1 |
| Sarna, S | 1 |
| Joensuu, H | 1 |
| Mattson, K | 1 |
| Roques, B | 1 |
| Pichon, A | 1 |
| De Laroche, G | 1 |
| Garnier, JF | 1 |
| Jacquin, JP | 1 |
| Bourgeois, Y | 1 |
| Arvelo, F | 1 |
| Scott, C | 1 |
| Movsas, B | 1 |
| Wagner, H | 1 |
| Freyer, G | 1 |
| Tranchand, B | 1 |
| Ligneau, B | 1 |
| Ardiet, C | 1 |
| Souquet, PJ | 1 |
| Rebattu, P | 1 |
| Boissel, JP | 1 |
| Girard, P | 1 |
| Vanhees, SL | 1 |
| Paridaens, R | 1 |
| Vansteenkiste, JF | 1 |
| Tourani, JM | 1 |
| Jaillon-Abraham, C | 1 |
| Coscas, Y | 1 |
| Dabouis, G | 1 |
| Andrieu, JM | 1 |
| Sayit, E | 1 |
| Aktoğu, S | 1 |
| Ertay, T | 1 |
| Capa, G | 1 |
| Erkmen, G | 1 |
| Ozbilek, E | 1 |
| Büyükşirin, M | 1 |
| Durak, H | 1 |
| Fukuoka, S | 1 |
| Johnson, PW | 1 |
| Gurney, EM | 1 |
| Napp, VV | 1 |
| Hepburn, PM | 1 |
| Simms, T | 1 |
| Davies, R | 1 |
| Woo, IS | 1 |
| Park, YS | 1 |
| Kwon, SH | 1 |
| Park, YL | 1 |
| Lee, JA | 1 |
| Park, MJ | 1 |
| Hyun, IG | 1 |
| Jung, KS | 1 |
| Bae, HS | 1 |
| Oh, DH | 1 |
| Kim, WS | 1 |
| Park, CH | 1 |
| Kim, HJ | 1 |
| Ahn, YC | 1 |
| Luthra, K | 1 |
| Wozniak, AJ | 1 |
| Behera, D | 1 |
| Aggarwal, AN | 1 |
| Sharma, SC | 1 |
| Gupta, D | 1 |
| Jindal, SK | 1 |
| Szopiński, J | 1 |
| Ponarska, A | 1 |
| Rogińska, E | 1 |
| Rogala, E | 1 |
| Rowińska-Zakrzewska, E | 1 |
| van Putten, JW | 1 |
| Kerbush, T | 1 |
| van Rijswijk, R | 1 |
| Beijnen, JH | 2 |
| Sleijfer, DT | 1 |
| Kerbusch, T | 1 |
| vanPutten, JW | 1 |
| Huitema, AD | 1 |
| Mathĵt, RA | 1 |
| Hosomi, Y | 2 |
| Shibuya, M | 2 |
| Lafitte, JJ | 1 |
| Berghmans, T | 1 |
| Koumakis, G | 1 |
| Florin, MC | 1 |
| Ninane, V | 1 |
| Hanna, N | 1 |
| Shen, J | 1 |
| Jung, SH | 2 |
| Hanna, NH | 1 |
| Sandier, AB | 1 |
| Lane, K | 1 |
| Calderoni, A | 1 |
| von Briel, C | 1 |
| Aebi, S | 1 |
| Solenthaler, M | 1 |
| Betticher, DC | 1 |
| Gagliano, R | 1 |
| Loukas, D | 1 |
| Panettiere, FJ | 1 |
| Hokanson, JA | 1 |
| Cohen, MH | 2 |
| Chretien, PB | 1 |
| Ihde, DC | 2 |
| Fossieck, BE | 2 |
| Makuch, R | 2 |
| Johnston, AV | 1 |
| Shackney, SE | 2 |
| Matthews, MJ | 2 |
| Lipson, SD | 1 |
| Kenady, DE | 1 |
| Minna, JD | 2 |
| Johnston-Early, A | 1 |
| Rynard, S | 1 |
| Songer, J | 1 |
| Pennington, K | 1 |
| Einhorn, L | 1 |
| Palmen, FM | 1 |
| Carney, DN | 2 |
| Vendrik, C | 2 |
| Roozendaal, K | 2 |
| Planting, AS | 1 |
| Quoix, E | 2 |
| Williams, SD | 1 |
| Lind, M | 3 |
| Cerny, T | 3 |
| Berendsen, HH | 1 |
| García Gómez, R | 1 |
| García Arroyo, R | 1 |
| Meana García, A | 1 |
| Martínez del Prado, P | 1 |
| González del Val, R | 1 |
| Pérez Manga, G | 1 |
| Miyamoto, H | 2 |
| Nakabayashi, T | 2 |
| Isobe, H | 1 |
| Akita, H | 1 |
| Kawakami, Y | 2 |
| Asakawa, M | 2 |
| Suzuki, A | 2 |
| Fujikane, T | 2 |
| Shimizu, T | 2 |
| Stewart, D | 1 |
| Maroun, J | 1 |
| Monnet, I | 1 |
| Chariot, P | 1 |
| Ruffié, P | 2 |
| Voisin, S | 1 |
| Le Chevalier, T | 2 |
| Saltiel, JC | 1 |
| de Cremoux, H | 1 |
| Smith, IE | 3 |
| Thomas, F | 1 |
| Subirana, R | 1 |
| Baldeyrou, P | 1 |
| Arriagada, R | 1 |
| Chazard, M | 1 |
| Tursz, T | 1 |
| Onodera, S | 1 |
| Yasuda, S | 1 |
| Twelves, CJ | 1 |
| Goldman, J | 1 |
| Ash, CM | 2 |
| Souhami, RL | 2 |
| Harper, PG | 2 |
| Spiro, SG | 2 |
| Geddes, D | 1 |
| Tobias, JS | 2 |
| Wolf, M | 6 |
| Pritsch, M | 1 |
| Hans, K | 6 |
| Schroeder, M | 5 |
| Flechtner, H | 2 |
| Heim, M | 4 |
| Hruska, D | 1 |
| Mende, S | 2 |
| Becker, H | 3 |
| Ranson, M | 1 |
| Hoskin, PJ | 1 |
| Parton, D | 1 |
| Yarnold, JR | 2 |
| Cherryman, G | 1 |
| Weiss, RB | 1 |
| Maasberg, M | 1 |
| Pfab, R | 1 |
| Miles, DW | 1 |
| Earl, HM | 1 |
| Rudd, R | 1 |
| James, L | 1 |
| Trask, CW | 1 |
| Glisson, BS | 1 |
| Dhingra, HM | 1 |
| Umsawasdi, T | 1 |
| Levy, JK | 1 |
| Jeffries, D | 1 |
| Raber, MN | 1 |
| Lind, MJ | 2 |
| Woodcock, A | 1 |
| Carroll, KB | 2 |
| Perren, TJ | 1 |
| Ashley, SA | 1 |
| Woodiwiss, J | 1 |
| Forgeson, GV | 1 |
| Ford, HT | 1 |
| Trillet, V | 1 |
| Champel, F | 1 |
| Bernard, JP | 1 |
| Brune, J | 1 |
| Clavel, M | 1 |
| Emonot, A | 1 |
| Guérin, JC | 1 |
| Kalb, JC | 1 |
| Falkson, G | 1 |
| Chasen, MR | 1 |
| Falkson, HC | 1 |
| Kamthan, AG | 1 |
| Bronchud, MH | 1 |
| Ranson, MR | 1 |
| Holle, R | 5 |
| Harms, V | 1 |
| Dombrowski, H | 1 |
| Victor, N | 2 |
| Bronchud, M | 1 |
| Scarffe, JH | 1 |
| Crowther, D | 1 |
| Souza, LM | 1 |
| Alton, NK | 1 |
| Goerg, R | 1 |
| Bidoli, P | 1 |
| Spinazzé, S | 1 |
| Santoro, A | 1 |
| Bedini, AV | 1 |
| Cataldo, I | 1 |
| Bonadonna, G | 1 |
| Karnicka-Mlodkowska, H | 1 |
| Orel, J | 1 |
| Salzer, GM | 1 |
| Thermann, M | 1 |
| Lattuneddu, A | 1 |
| Sun, Y | 1 |
| Hata, E | 1 |
| Payne, C | 1 |
| Campbell, C | 1 |
| Moussalli, H | 1 |
| Watkin, SW | 1 |
| Errington, RD | 2 |
| Green, JA | 2 |
| Warenius, HM | 2 |
| Hardman, PD | 1 |
| Myint, S | 1 |
| Barber, PV | 1 |
| Wolstenholme, RJ | 1 |
| Barnes, P | 1 |
| Deiraniya, A | 1 |
| Dommes, M | 1 |
| Cantwell, BM | 3 |
| Bozzino, JM | 2 |
| Corris, P | 1 |
| Tsujii, H | 1 |
| Irie, G | 1 |
| Dalesio, O | 1 |
| Palmen, FJ | 1 |
| Burghouts, J | 1 |
| Planting, A | 1 |
| Bülzebruck, H | 2 |
| Djawid, N | 1 |
| Ruchalla, E | 1 |
| Tessen, HW | 1 |
| Paschke, R | 1 |
| Worst, P | 1 |
| Brust, J | 1 |
| Lange, OF | 1 |
| Hossfeld, DK | 1 |
| Radenbach, D | 1 |
| Zschaber, R | 1 |
| Birch, R | 1 |
| Kramer, BS | 1 |
| Greco, FA | 1 |
| Höfeler, H | 1 |
| Höffken, K | 1 |
| Schoetensack, B | 1 |
| Wandl, U | 1 |
| Kath, R | 1 |
| Müller, M | 1 |
| Tsukagoshi, S | 1 |
| Frankmann, C | 1 |
| Benjamin, RS | 1 |
| McMurtrey, MJ | 1 |
| Jeffries, DG | 1 |
| Welch, SR | 1 |
| Smith, DB | 1 |
| Webb, K | 1 |
| Hilton, A | 1 |
| Rahman, A | 1 |
| Klapsing, J | 1 |
| Viktor, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| RANDOMISED CLINICAL TRIAL OF IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE WITH MID-CYCLE VINCRISTINE (VICE) VERSUS STANDARD PRACTICE CHEMOTHERAPY IN PATIENTS WITH LIMITED STAGE SMALL CELL LUNG CANCER (SCLC) AND GOOD PERFORMANCE STATUS[NCT00002822] | Phase 3 | 400 participants (Anticipated) | Interventional | 1996-03-31 | Completed | ||
| Phase II Multicenter Study Evaluating the Efficacy of Carboplatin-Etoposide Combination in Hormone-resistant Prostate Cancers With Neuroendocrine Differentiation.[NCT00973882] | Phase 2 | 60 participants (Actual) | Interventional | 2005-04-30 | Completed | ||
| A Phase Ⅱ Randomized Clinical Trial Comparing Vinorelbine-ifosfamide With Gefitinib as Third-line Treatment in Advanced EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients[NCT01749072] | Phase 2 | 120 participants (Anticipated) | Interventional | 2012-12-31 | Recruiting | ||
| A Phase Ⅱ Single-arm Clinical Trial to Investigate the Efficacy and Safety of Vinorelbine-ifosfamide Regimen as Third-line Treatment in Refractory or Recurrent Extensive Small Cell Lung Cancer Patients[NCT01752517] | 60 participants (Anticipated) | Observational | 2012-12-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
29 reviews available for ifosfamide and Carcinoma, Small Cell
| Article | Year |
|---|---|
Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Ce | 2023 |
Small cell carcinoma of the bladder: a case report and a literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Small Cell; | 2003 |
Chemotherapy versus best supportive care for extensive small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Humans; Ifosfamide; Lomustine | 2003 |
Ifosfamide in small cell lung cancer.
Topics: Antineoplastic Agents, Alkylating; Carcinoma, Small Cell; Humans; Ifosfamide; Lung Neoplasms; Surviv | 2003 |
Chemotherapy of small cell lung cancer: state of the art.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Smal | 2004 |
In vivo efficacy of STI571 in xenografted human small cell lung cancer alone or combined with chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Carcinoma, Small Cel | 2005 |
Combined resection and multi-agent adjuvant chemotherapy for intra-abdominal desmoplastic small round cell tumour: case report and review of the literature.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adj | 2007 |
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Sm | 1983 |
Oral therapy for small cell lung cancer.
Topics: Administration, Oral; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Proto | 1995 |
The role of ifosfamide in germ cell tumors and small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Ger | 1995 |
Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Clinical Trials | 1995 |
[A case of small cell lung cancer associated with fulminant hepatitis B].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; E | 1994 |
The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Clini | 1995 |
[Chemotherapy of small-cell lung cancer by a combination of teniposide, ifosfamide and carboplatin].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Fem | 1994 |
Intensive combined-modality therapy in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Ad | 1994 |
Ifosfamide in the treatment of small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineo | 1996 |
The role of ifosfamide in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Humans; Ifosfamide; Lung Neop | 1996 |
[Small cell carcinoma of the urinary bladder: a case report and review of the Japanese literature].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality | 1997 |
Etoposide plus ifosfamide plus cisplatin in the treatment of small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as | 1998 |
Paratesticular desmoplastic small round cell tumor: case report and review of the literature.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality | 1999 |
Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Humans; Hyponatrem | 2000 |
[Combination chemotherapy with VP-16 in the treatment of lung cancer and malignant lymphoma].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carc | 2001 |
[ Early anti-cancer drugs].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun | 2002 |
Clinical trials with ifosfamide: the Indiana University experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Humans; Ifosfamide; Indiana; | 1992 |
Overview of ifosfamide in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Protocols; Humans; I | 1992 |
Novel approaches with ifosfamide in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Protocols; Humans; I | 1992 |
Overview of ifosfamide in small cell and non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cel | 1990 |
[Small cell lung carcinoma. Value of the evaluation of extension for the therapeutic strategy].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clin | 1990 |
Ifosfamide in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; | 1989 |
110 trials available for ifosfamide and Carcinoma, Small Cell
| Article | Year |
|---|---|
Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Car | 2009 |
Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588).
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemo | 2002 |
Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with stem cell rescue for small-cell lung cancer: brief report on the results of a phase-I/II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Carcinom | 2002 |
Outpatient intensive chemotherapy for small cell lung cancer: five years experience of modified 'ICE' ifosfamide carboplatin and etoposide.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small | 2002 |
Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Femal | 2003 |
Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug | 2003 |
Combination chemotherapy with irinotecan and ifosfamide as second-line treatment of refractory or sensitive relapsed small cell lung cancer: a phase II study.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Co | 2003 |
Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dos | 2005 |
Double-cycle, high-dose ifosfamide, carboplatin, and etoposide followed by peripheral blood stem-cell transplantation for small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com | 2005 |
Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: clinical and quality-of-life results of the British Medical Research Council multicenter ran
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcino | 2005 |
Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biop | 2007 |
Standard versus dose-intensified chemotherapy with sequential reinfusion of hematopoietic progenitor cells in small cell lung cancer patients with favorable prognosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com | 2007 |
Neurocognitive function in patients with small cell lung cancer : effect of prophylactic cranial irradiation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cogni | 2008 |
A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Co | 2008 |
Chemoimmunotherapy of small cell bronchogenic carcinoma with VP-16-213, ifosfamide, vincristine, adriamycin, and Corynebacterium parvum.
Topics: Adult; Aged; Antineoplastic Agents; Bacterial Vaccines; Brain; Carcinoma, Small Cell; Clinical Trial | 1981 |
[Ifosfamide versus ifosfamide + CCNU in the treatment of inoperable small cell carcinoma of the lung. A clinical study].
Topics: Adult; Aged; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combin | 1982 |
Parenteral intravenous nutrition (PIVN) as an adjunct to chemotherapy in small cell anaplastic lung carcinoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Marr | 1981 |
Single-dose ifosfamide: efficacy studies in non-small cell lung cancer.
Topics: Actuarial Analysis; Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cl | 1982 |
Use and safety of high-dose ifosfamide.
Topics: Adenocarcinoma; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Cyc | 1982 |
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Sm | 1983 |
A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Carcinoma, Small Cel | 1993 |
Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin.
Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Ble | 1994 |
Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion, Autologous; Carboplatin; C | 1995 |
Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cis | 1995 |
Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Sma | 1995 |
A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, No | 1995 |
Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; | 1995 |
Single fraction prophylactic cranial irradiation for small cell carcinoma of the lung.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; | 1995 |
Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, | 1995 |
Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small C | 1995 |
Pharmacokinetics of ifosfamide and its enantiomers following a single 1 h intravenous infusion of the racemate in patients with small cell lung carcinoma.
Topics: Aged; Carcinoma, Small Cell; Female; Half-Life; Humans; Ifosfamide; Infusions, Intravenous; Lung Neo | 1995 |
Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group Trial.
Topics: Administration, Oral; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcino | 1995 |
Ifosfamide, doxorubicin, vincristine, and etoposide in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modalit | 1995 |
Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: experience of the European Lung Cancer Working Party.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Doxorubicin; Epi | 1995 |
The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Clini | 1995 |
Hoosier Oncology Group studies in extensive and recurrent small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etopo | 1995 |
Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epirubicin; Female | 1994 |
Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy. Final results of a multicentric pilot study for the Groupe Lyonnias d'Oncologie Thoracique (GLOT).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modalit | 1993 |
A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Wor
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cause of Death; | 1993 |
Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: a phase II study of the EORTC Lung Cancer Cooperative Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cyc | 1993 |
A randomised study of bolus vs continuous pump infusion of ifosfamide and doxorubicin with oral etoposide for small cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small | 1993 |
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Disease-Free Sur | 1996 |
Intensified VICE regimen may improve SCLC survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Disease-Free Sur | 1996 |
Pilot study of ambulatory infusional delivery of a multidrug regimen: ifosfamide, carboplatin and etoposide (ICE).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anemia; Antineoplastic Combined Che | 1996 |
The limits of chemotherapy dose intensification using granulocyte colony stimulating factor alone in extensive small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Dose-Response Relationship, D | 1996 |
Interferon alpha-2a and combined chemotherapy as first line treatment in SCLC patients: a randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com | 1996 |
Sequential high-dose ICE chemotherapy with circulating progenitor cells (CPC) in small cell lung cancer: an EBMT study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined | 1996 |
Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Carbopl | 1996 |
Urinary excretion of ifosfamide, 4-hydroxyifosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Carcinoma, Bronchoge | 1997 |
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carc | 1997 |
Ifosfamide, cisplatin and etoposide (ICE) combined chemotherapy with recombinant human granulocyte colony-stimulating factor support in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etopo | 1997 |
Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Drug Admin | 1997 |
Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 1997 |
Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineo | 1998 |
Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cohor | 1998 |
Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dou | 1998 |
Ifosfamide-based chemotherapy for previously treated lung cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcino | 1998 |
Modified ice study: a phase II study of an intensive, modified ICE regimen (ifosfamide, carboplatin and etoposide) in patients with better prognosis, small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combi | 1998 |
Phase II study of hyperfractionated radiotherapy and concurrent weekly alternating chemotherapy in limited-stage small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophospha | 1998 |
Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis: a study of the Hellenic Cooperative Oncology Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cra | 1999 |
A pilot study of increasing dose intensity of epirubicin and ifosfamide in patients with small cell lung cancer by using recombinant granulocyte colony-stimulating factor.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemot | 1999 |
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cis | 1999 |
Modifying the ICE regimen for better prognosis small cell lung cancer--an update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; | 1999 |
Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow Transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Dose- | 1999 |
Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clini
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined M | 1999 |
A phase I dose escalation study of multicyclic, dose-intensive chemotherapy with peripheral blood stem cell support for small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com | 2000 |
Interferon-alpha and 13-cis-retinoic acid as maintenance therapy after high-dose combination chemotherapy with growth factor support for small cell lung cancer--a feasibility study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carc | 2000 |
Phase II study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dos | 2000 |
Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemoth | 2000 |
Combination of cisplatin, ifosfamide, and irinotecan with rhG-CSF support for the treatment of refractory or relapsed small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Ci | 2000 |
Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study.
Topics: Aged; Antineoplastic Agents; Carcinoma, Small Cell; Doxorubicin; Etoposide; Humans; Ifosfamide; Lung | 2000 |
Feasibility and preliminary results of intensive chemotherapy and extensive irradiation in selected patients with limited small-cell lung carcinoma--results of three consecutive phase II programs.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide | 2000 |
Effect of chemotherapy on pulmonary epithelial permeability in lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Gas Analysis; Carcinoma, Non-Small-Cell Lung; | 2000 |
A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer.
Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Sma | 2001 |
Use of hematopoietic progenitors in whole blood to support dose-dense chemotherapy: a randomized phase II trial in small-cell lung cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Carboplatin; Carcinoma | 2001 |
A phase II study of VP-16-fosfamide-cisplatin combination chemotherapy plus early concurrent thoracic irradiation for previously untreated limited small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combi | 2000 |
A phase II study of weekly alternating chemotherapy in extensive-stage small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclo | 2001 |
Combination chemotherapy for extensive small cell lung cancer -- experience from India.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Administrat | 2001 |
[The effect of small cell lung cancer extension on secretion of interleukin-2 (IL-2) and interferon gamma (IFM gamma) in whole blood culture stimulated with mitogens].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epiru | 2001 |
Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carb | 2001 |
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Proto | 2001 |
Etoposide, ifosfamide and cisplatin (VIP) plus concurrent radiation therapy for previously untreated limited small cell lung cancer (SCLC): a Hoosier Oncology Group (HOG) phase II study.
Topics: Adult; Aged; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; | 2002 |
Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small | 2002 |
Intensive chemotherapy with whole blood stem-cell support and concurrent chest radiotherapy in small cell lung cancer: a phase I/II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chi | 2002 |
Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combinati | 1979 |
Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin | 1979 |
Etoposide, ifosfamide, and cisplatin in extensive small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; | 1992 |
Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell lung cancer in a randomised phase II study. The EORTC Lung Cancer Cooperative group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cyc | 1992 |
Second-line carboplatin-based chemotherapy for small cell lung cancer: the Groningen experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Car | 1992 |
A phase III comparison of etoposide/cisplatin with or without added ifosfamide in small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etopo | 1992 |
A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etopo | 1992 |
Extensive small-cell lung cancer. A randomized comparison of two chemotherapy programs with early crossover in instances of failure. Association pour le Traitement des Tumeurs Intra-Thoraciques (ATTIT).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cis | 1992 |
Carboplatin in small cell lung cancer: the Royal Marsden Hospital experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 1992 |
[Cisplatin etoposide versus cisplatin/etoposide/ifosfamide combination chemotherapy in small-cell lung cancer: a multicenter randomized controlled study. Hokkaido Study Group of Treatment for Small-Cell Lung Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; F | 1991 |
Sequential chemotherapy in good-prognosis patients with small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Thera | 1991 |
Cyclic-alternating versus response-oriented chemotherapy in small-cell lung cancer: a German multicenter randomized trial of 321 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide | 1991 |
A randomised study of intravenous bolus versus continuous infusion of ifosfamide and doxorubicin with oral etoposide for small-cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small | 1991 |
[Small cell lung carcinoma. Value of the evaluation of extension for the therapeutic strategy].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clin | 1990 |
The prognostic value of response to the first cycle of chemotherapy in small cell lung cancer. Results of a multicenter German trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Clinical Trials as | 1987 |
Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophospha | 1989 |
The role of ifosfamide and cyclophosphamide in the multi-modality treatment after surgery for cure for small-cell bronchial carcinomas (SCLC).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Small Cell; Combined | 1989 |
Treatment of small cell lung cancer with induction chemotherapy followed by late intensification.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Cyc | 1989 |
Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clini | 1987 |
Two carboplatin-containing regimens for small cell lung cancer: preliminary results of a randomized phase II trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Evaluation; | 1988 |
Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.
Topics: Acetylcysteine; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic | 1986 |
Alternating versus sequential chemotherapy in small cell lung cancer. A randomized German multicenter trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; | 1987 |
Experience with 24-h infusions of ifosfamide/mesna in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Evaluation; Humans; Ifos | 1986 |
Two randomized trials for alternating polychemotherapy of small cell lung cancer.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clini | 1986 |
"Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial".
Topics: Acetylcysteine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carc | 1987 |
[Treatment of oat cell metastazing bronchial carcinoma with isofosfamide. Results of a prospective randomized study].
Topics: Aged; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Humans; If | 1974 |
73 other studies available for ifosfamide and Carcinoma, Small Cell
| Article | Year |
|---|---|
Effects and toxicity of neoadjuvant chemotherapy preoperative followed by adjuvant chemoradiation in small cell neurdendocrine cervical carcinoma.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Neuroendo | 2015 |
Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Sma | 2015 |
Epirubicin and ifosfamide in relapsed or refractory small cell lung cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Epirubicin; Female; Humans; I | 2012 |
Modified Ifosphamide/CarboPlatin/Etoposide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Human | 2003 |
[Maintenance chemotherapy for small-cell lung cancer. A new publication].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administratio | 2003 |
Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer.
Topics: Age Factors; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell | 2005 |
Adjuvant surgery after carboplatin and VP16 in resectable small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Small Cell; Cisplatin; Etoposide; | 2007 |
Combination chemotherapy with paclitaxel and ifosfamide as the third-line regimen in patients with heavily pretreated small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Therapy, Co | 2007 |
Ifosfamide-related encephalopathy in elderly patients : report of five cases and review of the literature.
Topics: Abdominal Neoplasms; Aged; Antidotes; Antineoplastic Agents, Alkylating; Antineoplastic Combined Che | 2007 |
Diseases desperate grown.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Disease-Free Sur | 2008 |
[Chemotherapy of the non-small cell carcinoma of the lung with ifosfamide and cisplatin].
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; C | 1984 |
[3 multicenter phase II studies of the treatment of small cell bronchogenic carcinoma (incl. AIO studies BI + BII)].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Ca | 1984 |
Pilot study of intravenous ifosfamide plus oral acetylcysteine in the treatment of non-small cell lung cancer.
Topics: Acetylcysteine; Adenocarcinoma; Administration, Oral; Carcinoma; Carcinoma, Small Cell; Carcinoma, S | 1981 |
[Prevention of recurrence of small-cell lung cancer by adjuvant polychemotherapy (author's transl)].
Topics: Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Human | 1982 |
Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-16), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO).
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug | 1982 |
Small cell lung cancer. Serial bronchofiberscopy and photographic documentation--the bridge sign.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bronchoscopy; Carcino | 1983 |
Ifosfamide in the treatment of extensive non-oat cell carcinoma of the lung.
Topics: Adenocarcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Administrati | 1982 |
[Toxic-allergic lung edema following cyclophosphamide and ifosfamide therapy. Case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin | 1983 |
[Ifosfamide in the treatment of small cell carcinoma of the lung].
Topics: Adult; Aged; Carcinoma, Small Cell; Cyclophosphamide; Cystitis; Drug Administration Schedule; Drug T | 1983 |
Effects of intensive induction chemotherapy for extensive-disease small cell bronchogenic carcinoma in protected environment-prophylactic antibiotic units.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carcinoma, Bronch | 1984 |
Experimental basis and clinical experience with non-cross-resistant combinations in solid tumours.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bro | 1984 |
Ifosfamide, carboplatin and etoposide for good prognosis small cell lung cancer: are four courses inadequate? West of Scotland Lung Cancer Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Eto | 1995 |
Reversible myocardial ischaemia following vincristine containing chemotherapy.
Topics: Carcinoma, Small Cell; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Middle Aged; Myocardia | 1994 |
Therapy for small cell lung cancer using carboplatin, ifosfamide, etoposide (without dose reduction), mid-cycle vincristine with thoracic and cranial irradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; | 1994 |
Ifosfamide, epirubicin and cisplatin (IEP): another active combination for small cell lung cancer (SCLC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epiru | 1993 |
Teniposide for meningeal carcinomatosis of small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cyc | 1993 |
VP-16, ifosfamide and cisplatin (VIP) for extensive small cell lung cancer.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; | 1994 |
Ifosfamide neurotoxicity. A challenge for nurses, a potential nightmare for patients.
Topics: Brain Diseases; Carcinoma, Small Cell; Central Nervous System; Female; Humans; Ifosfamide; Lung Neop | 1993 |
Management of small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; | 1993 |
An unusual case of haematuria.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide | 1993 |
Antitumor activity of treosulfan in human lung carcinomas.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Anti | 1996 |
Response of small cell carcinoma of pancreas to a small cell lung cancer regimen: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cy | 1996 |
Experience with ifosfamide and etoposide combination chemotherapy in extensive-disease small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Etoposide; Humans; Ifos | 1997 |
[Pilot study of cisplatin, ifosfamide and irinotecan (CPT-11) with granulocyte colony-stimulating factor support (CIC-regimen) in relapsed small-cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Ci | 1998 |
Management of chemotherapy-related anaemia with low-dose recombinant human erythropoietin in patients with small cell lung cancer.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Erythrop | 1997 |
Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cyc | 1998 |
Cost comparison between PAV and ICE treatment with peripheral blood progenitor cells (PBPC) reinfusion in small-cell lung cancer (SCLC)
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxorubicin; | 1999 |
[Intra-abdominal desmoplastic small round-cell tumors. An entity among peritoneal carcinomatoses in young adults].
Topics: Abdominal Neoplasms; Abdominal Pain; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protoco | 2000 |
Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cell Division; Cispl | 2000 |
Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Carcinom | 2000 |
Population pharmacokinetics of ifosfamide and its 2- and 3-dechloroethylated and 4-hydroxylated metabolites in resistant small-cell lung cancer patients.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Area Under Curve; Carcinoma, Small Cell; Drug Resist | 2001 |
Ifosfamide in the treatment of recurrent or disseminated lung cancer: a phase II study of two dose schedules.
Topics: Adenocarcinoma; Adult; Aged; Bone Marrow; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cyclophos | 1978 |
[Chemotherapy with cisplatin, adriamycin, etoposide and ifosfamide in microcytic lung carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxor | 1992 |
A phase II study of the combination of carboplatin and ifosfamide in previously untreated metastatic small cell lung carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, | 1991 |
Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cis | 1991 |
Intercalated radio-chemotherapy in small cell lung cancer: toxicity and implications for future regimens.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com | 1991 |
Ifosfamide vs cyclophosphamide in cancer therapy.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cyclophosphamide; Female; Genital Neoplasms, | 1991 |
Combined chemo- and radiosensitivity testing with ifosfamide and ACNU in human lung cancer cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cel | 1991 |
Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxor | 1991 |
Ifosfamide with mesna uroprotection in the management of lung cancer.
Topics: Aged; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans | 1990 |
Therapy for poor-risk patients with small-cell lung cancer using bolus ifosfamide and oral etoposide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Etoposide; Female; Huma | 1990 |
Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com | 1990 |
Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer.
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small | 1990 |
Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Doxorubicin; Eto | 1990 |
Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Colony-Stimulating Factors; D | 1988 |
Pilot study with adriamycin and ifosfamide in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Doxorubicin; Fem | 1989 |
A simple outpatient treatment with oral ifosfamide and oral etoposide for patients with small cell lung cancer (SCLC).
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Chemo | 1989 |
Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com | 1989 |
Sequential combination chemotherapy and radiotherapy in locally advanced non-small cell carcinoma of the bronchus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Small C | 1989 |
Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modalit | 1987 |
The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16-213, doxorubicin and vincristine (VPAV) for small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modalit | 1988 |
[The role of radiotherapy in small cell lung cancer].
Topics: Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Ifosfamide; | 1988 |
[Chemotherapy of non-small cell bronchial cancer with ifosfamide in combination with cisplatin, etoposide or vindesine].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun | 1988 |
[Hepatotoxicity with etoposide-ifosfamide combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cel | 1988 |
Concurrent chemo-radiotherapy in small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Small Cell; Carmustine; Combined Modality Therapy; Female; Humans; Ifosfamid | 1988 |
Ifosfamide/mesa and encephalopathy.
Topics: Brain Diseases; Carcinoma, Small Cell; Cyclophosphamide; Female; Humans; Ifosfamide; Lung Neoplasms; | 1985 |
[Treatment of non-small-cell bronchial carcinoma with cisplatin, ifosfamide, vindesine and VP 16].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic | 1985 |
[Chemotherapy with mitomycin C, vindesine and ifosfamide in the treatment of inoperable non-small cell bronchial carcinoma].
Topics: Adenocarcinoma; Aged; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug | 1985 |
[Therapy of primary resistant or recurrent small cell bronchial carcinoma with vindesine and ifosfamide].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Administration Schedule; | 1986 |
[Ifomide].
Topics: Animals; Bone Neoplasms; Carcinoma, Small Cell; Female; Humans; Ifosfamide; Leukemia, Experimental; | 1987 |
Long-term effects of intravenous hyperalimentation administered during intensive chemotherapy for small cell bronchogenic carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcino | 1987 |
Ifosfamide by bolus as treatment for advanced non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Small Cell; Drug Administration Schedule; Female; Humans; Ifosfamide; Inject | 1986 |
Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; | 1986 |